• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过大型α-1抗胰蛋白酶缺乏症筛查项目鉴定的新型SERPINA1等位基因及已知变异的综述。

Novel SERPINA1 Alleles Identified through a Large Alpha-1 Antitrypsin Deficiency Screening Program and Review of Known Variants.

作者信息

Wiesemann Gayle S, Oshins Regina A, Flagg Tammy O, Brantly Mark L

机构信息

University of Florida College of Medicine, Gainesville, Florida, United States.

Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, Florida, United States.

出版信息

Chronic Obstr Pulm Dis. 2023 Jan 25;10(1):7-21. doi: 10.15326/jcopdf.2022.0321.

DOI:10.15326/jcopdf.2022.0321
PMID:36367950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9995231/
Abstract

The gene encodes the serine protease inhibitor alpha-1 antitrypsin (AAT) and is located on chromosome 14q31-32.3 in a cluster of homologous genes likely formed by exon duplication. AAT has a variety of anti-inflammatory properties. Its clinical relevance is best illustrated by the genetic disease alpha-1 antitrypsin deficiency (AATD) which is associated with an increased risk for chronic obstructive pulmonary disease (COPD) and cirrhosis. While 2 single nucleotide polymorphisms (SNPs) , S and Z, are responsible for more than 95% of all individuals with AATD, there are a number of rare variants associated with deficiency and dysfunction, as well as those associated with normal levels and function. Our laboratory has identified a number of novel AAT alleles that we report in this manuscript. We screened more than 500,000 individuals for AATD alleles through our testing program over the past 20 years. The characterization of these alleles was accomplished by DNA sequencing, measurement of AAT plasma levels and isoelectric focusing at pH 4-5. We report 22 novel AAT alleles discovered through our screening programs, such as Z and QO, and review the current literature of known AAT genetic variants.

摘要

该基因编码丝氨酸蛋白酶抑制剂α-1抗胰蛋白酶(AAT),位于14号染色体q31 - 32.3上,处于一个可能由外显子重复形成的同源基因簇中。AAT具有多种抗炎特性。其临床相关性在α-1抗胰蛋白酶缺乏症(AATD)这一遗传疾病中得到了最好的体现,该疾病与慢性阻塞性肺疾病(COPD)和肝硬化风险增加相关。虽然2个单核苷酸多态性(SNP),即S和Z,导致了超过95%的AATD个体,但也存在一些与缺乏和功能障碍相关的罕见变异,以及与正常水平和功能相关的变异。我们实验室在本手稿中报告了一些新发现的AAT等位基因。在过去20年里,我们通过检测项目对超过50万人进行了AATD等位基因筛查。这些等位基因的特征通过DNA测序、AAT血浆水平测量以及pH 4 - 5条件下的等电聚焦来确定。我们报告了通过筛查项目发现的22个新的AAT等位基因,如Z和QO,并综述了已知AAT基因变异的当前文献。

相似文献

1
Novel SERPINA1 Alleles Identified through a Large Alpha-1 Antitrypsin Deficiency Screening Program and Review of Known Variants.通过大型α-1抗胰蛋白酶缺乏症筛查项目鉴定的新型SERPINA1等位基因及已知变异的综述。
Chronic Obstr Pulm Dis. 2023 Jan 25;10(1):7-21. doi: 10.15326/jcopdf.2022.0321.
2
Alpha-1 Antitrypsin Deficiencyα-1抗胰蛋白酶缺乏症
3
Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.利用蛋白质建模技术评估疑似患有α1-抗胰蛋白酶缺乏症患者的 SERPINA1 罕见变异体的致病性。
BMC Med Genet. 2019 Jul 15;20(1):125. doi: 10.1186/s12881-019-0852-5.
4
Clinical presentations of four patients with rare Alpha 1 Antitrypsin variants identified in a single US center.在美国一个中心发现的4例罕见α1抗胰蛋白酶变体患者的临床表现。
Respir Med Case Rep. 2021 Jan 20;32:101345. doi: 10.1016/j.rmcr.2021.101345. eCollection 2021.
5
Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?与基于α1抗胰蛋白酶(AAT)浓度的筛查方法相比,综合实验室算法在检测慢性阻塞性肺疾病(COPD)患者α1抗胰蛋白酶缺乏症方面是否更有效?
Biochem Med (Zagreb). 2014;24(2):293-8. doi: 10.11613/BM.2014.032. Epub 2014 Jun 15.
6
Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of Variation Spectrum.导致α-1抗胰蛋白酶缺乏症的已知突变:变异谱的最新概述
Appl Clin Genet. 2021 Mar 22;14:173-194. doi: 10.2147/TACG.S257511. eCollection 2021.
7
New -Acting Variants in PI*S Background Produce Null Phenotypes Causing Alpha-1 Antitrypsin Deficiency.新型 PI*S 背景下的变异导致产生无效表型,引起α-1 抗胰蛋白酶缺乏症。
Am J Respir Cell Mol Biol. 2020 Oct;63(4):444-451. doi: 10.1165/rcmb.2020-0021OC.
8
Granularity of alleles by DNA sequencing in CanCOLD.加拿大慢性阻塞性肺疾病遗传队列研究中通过DNA测序得到的等位基因粒度
Eur Respir J. 2020 Oct 15;56(4). doi: 10.1183/13993003.00958-2020. Print 2020 Oct.
9
New variants of alpha-1-antitrypsin: structural simulations and clinical expression.新型α-1-抗胰蛋白酶变异体:结构模拟与临床表型。
Respir Res. 2022 Dec 10;23(1):339. doi: 10.1186/s12931-022-02271-8.
10
Identification and characterisation of eight novel SERPINA1 Null mutations.八个新型丝氨酸蛋白酶抑制剂A1(SERPINA1)无效突变的鉴定与特征分析
Orphanet J Rare Dis. 2014 Nov 26;9:172. doi: 10.1186/s13023-014-0172-y.

引用本文的文献

1
Spatial covariance reveals isothiocyanate natural products adjust redox stress to restore function in alpha-1-antitrypsin deficiency.空间协方差显示异硫氰酸酯天然产物可调节氧化还原应激以恢复α-1-抗胰蛋白酶缺乏症中的功能。
Cell Rep Med. 2025 Jan 21;6(1):101917. doi: 10.1016/j.xcrm.2024.101917. Epub 2025 Jan 13.
2
Clinical implications of the SERPINA1 variant, M, and alpha-1 antitrypsin deficiency in Türkiye.丝氨酸蛋白酶抑制剂A1(SERPINA1)变体M及α-1抗胰蛋白酶缺乏症在土耳其的临床意义。
BMC Pulm Med. 2024 Dec 18;24(1):622. doi: 10.1186/s12890-024-03421-y.
3
Alpha-1 antitrypsin deficiency associated with rare alleles p.(Phe76del) and p.(Asp280Val): A family study.与罕见等位基因p.(Phe76del)和p.(Asp280Val)相关的α-1抗胰蛋白酶缺乏症:一项家族研究。
Respir Med Case Rep. 2024 Aug 28;51:102097. doi: 10.1016/j.rmcr.2024.102097. eCollection 2024.
4
Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0.土耳其一例新型α1-抗胰蛋白酶缺失变异的病例报告:Q0。
BMC Pulm Med. 2024 Feb 21;24(1):91. doi: 10.1186/s12890-024-02900-6.
5
Distribution of alpha1 antitrypsin rare alleles in six countries: Results from the Progenika diagnostic network.在六个国家的α1 抗胰蛋白酶罕见等位基因的分布:来自 Progenika 诊断网络的结果。
Hum Genomics. 2023 Jun 5;17(1):48. doi: 10.1186/s40246-023-00497-1.

本文引用的文献

1
Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein.循环α-1-抗胰蛋白酶蛋白的翻译后修饰。
Int J Mol Sci. 2020 Dec 2;21(23):9187. doi: 10.3390/ijms21239187.
2
Description of 22 new alpha-1 antitrypsin genetic variants.描述 22 种新的α-1 抗胰蛋白酶遗传变异。
Orphanet J Rare Dis. 2018 Sep 17;13(1):161. doi: 10.1186/s13023-018-0897-0.
3
Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions.α-1抗胰蛋白酶缺乏症中的肝脏疾病:当前方法与未来方向
Curr Pathobiol Rep. 2017;5(3):243-252. doi: 10.1007/s40139-017-0147-5. Epub 2017 Jul 10.
4
Characterization of Novel Missense Variants of SERPINA1 Gene Causing Alpha-1 Antitrypsin Deficiency.鉴定导致α-1 抗胰蛋白酶缺乏症的 SERPINA1 基因突变的新型错义变异。
Am J Respir Cell Mol Biol. 2018 Jun;58(6):706-716. doi: 10.1165/rcmb.2017-0179OC.
5
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis.一种与α-1抗胰蛋白酶缺乏症和支气管扩张相关的新型丝氨酸蛋白酶抑制剂A-1(SERPINA-1)错义突变。
Lung. 2017 Oct;195(5):679-682. doi: 10.1007/s00408-017-0033-2. Epub 2017 Jul 1.
6
The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization.α-1-抗胰蛋白酶的病理性特伦托变体(E75V)在聚合过程中表现出非经典行为。
FEBS J. 2017 Jul;284(13):2110-2126. doi: 10.1111/febs.14111. Epub 2017 Jun 8.
7
Identification of a novel alpha1-antitrypsin variant.一种新型α1-抗胰蛋白酶变体的鉴定。
Respir Med Case Rep. 2016 Nov 18;20:64-67. doi: 10.1016/j.rmcr.2016.11.008. eCollection 2017.
8
Alpha-1-antitrypsin (SERPINA1) mutation spectrum: Three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal.α-1-抗胰蛋白酶(SERPINA1)突变谱:在葡萄牙鉴定出的三种新变体及罕见缺陷等位基因的单倍型特征
Respir Med. 2016 Jul;116:8-18. doi: 10.1016/j.rmed.2016.05.002. Epub 2016 May 3.
9
Alpha-1 antitrypsin deficiency caused by a novel mutation (p.Leu263Pro): Pi*ZQ0gaia - Q0gaia allele.由一种新突变(p.Leu263Pro)引起的α-1抗胰蛋白酶缺乏症:Pi*ZQ0gaia - Q0gaia等位基因
Rev Port Pneumol (2006). 2015 Aug 14. doi: 10.1016/j.rppnen.2015.07.002.
10
Deficiency Mutations of Alpha-1 Antitrypsin. Effects on Folding, Function, and Polymerization.α-1抗胰蛋白酶的缺陷突变。对折叠、功能和聚合的影响。
Am J Respir Cell Mol Biol. 2016 Jan;54(1):71-80. doi: 10.1165/rcmb.2015-0154OC.